Darifenacin improves symptoms in overactive bladder

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1449, 2004-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darifenacin: In the Treatment of Overactive Bladder

By Katherine F. Croom Gillian M. Keating

Drugs & Aging, Vol. 21, Iss. 13, 2004-01 ,pp. : 885-892

Adis International

Access to resources Recommend Favorite

Darifenacin: a novel M₃ muscarinic selective receptor antagonist for the treatment of overactive bladder

By Chapple Christopher R

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1493-1500

Informa Healthcare

Access to resources Recommend Favorite

The antimuscarinic agent solifenacin succinate can significantly improve symptoms of overactive bladder

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Darifenacin improves HRQOL in patients with OAB

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder

By Latini Jerilyn M Giannantoni Antonella

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1017-1027

Informa Healthcare

Access to resources Recommend Favorite